HIMS
Hims Hers Health Inc
$25.03
+6.63%
Price vs EBIT Yield
Current Valuation
- EBIT Yield
- 0.76%
- EV/EBIT
- 132.0x
- P/E Ratio
- 46.0x
- PEG Ratio
- 2.61
EV/EBIT Averages
- Median (Fair Value)
- 95.4x
- Industry (Damodaran)
- 20.3x
- 1-Year Avg
- 110.8x
- 3-Year Avg
- 98.6x
- 5-Year Avg
- 97.2x
- Min / Max
- -2133.5x / 321.9x
EBIT Growth
- YoY Growth
- -45.4%
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- Current Margin
- 2.0%
Financial Snapshot
- Market Cap
- $5.35B
- Enterprise Value
- $5.89B
- Revenue (TTM)
- $2.35B
- Dividend Yield
- -
Valuation Context
vs 5-Year Average
36%
Above average (potentially overvalued)
EBIT Yield
0.76%
Below average yield
vs Industry (Drugs (Pharmaceutica...)
550%
Above industry avg
Data Points
1253
daily data points